Skip to content

Uterine Fibroids-Effect of Ayurvedic regimen

Clinical Evaluation of Khadirarishta and Kanchanara guggulu in the management of Uterine Fibroids-An Exploratory study - IMR-UF-TVM

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2014/09/005018
Enrollment
40
Registered
2014-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Uterine Fibroids

Interventions

Intervention1: Khadirarishta Kanchanara Guggulu: Khadirarishta-30 mL twice a day after meals orally (9 Am and 9 PM ) for six consecutive months.

Sponsors

Central Council for Research in Ayurvedic Sciences CCRAS
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Symptomatic Females, 25-50 yrs Uterine fibroids, uterine size 2 cm but none >5 cm on U/S Pre menopausal ladies with Uterine Fibroids getting at least 1 menstrual period in last three months. Normal PAP smear.

Exclusion criteria

Exclusion criteria: Pregnancy, Lactation. Unexplained vaginal bleeding, cervical dysplasia, abnormal ovarian or adnexal mass. History of malignancy within the past 5 years. Use of estrogen or progesterone-containing compounds, such as oral contraceptives and hormone replacement therapy, within 8 weeks of study entry, including transdermal, injectable, vaginal and oral preparations. Use of herbal medication having estrogenic or antiestrogenic effect within the past 3 months. Known recent rapid growth of fibroids, defined as a doubling in size in six months. Haemoglobin level below 8gm% Patients suffering from any other major systemic illness necessitating long term drug Therapy

Design outcomes

Primary

MeasureTime frame
Changes in the clinical symptomsTimepoint: At base line 30th day, 60th day, 90th day, 120th day, 150th day and 180th day i.e at the time of trial completion

Secondary

MeasureTime frame
Changes in the size of fibroidsTimepoint: At the screening day, 90th day and end of the study (180th day)

Countries

India

Contacts

Public ContactDr S Indirakumari

Ayurveda Research Institute for Mother and Child Health care

drindirakumari56@gmail.com9446795133

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026